Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. (Q34577467)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S E Clark

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

R Carpenter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

R L Bowen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S W Duffy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J L Jones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

7 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

120-127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

17 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Analysis of integrin beta4 expression in human breast cancer: association with basal-like tumors and prognostic significance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Immunohistochemical categorisation of ductal carcinoma in situ of the breast

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Identification of a basal-like subtype of breast ductal carcinoma in situ

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Prognostic markers in triple-negative breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Classification of ductal carcinoma in situ by gene expression profiling

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

c-erbB-2 (HER-2/neu) immunohistochemistry in invasive breast cancer: is there concordance between standard sections and tissue microarrays?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Overdiagnosis and overtreatment of breast cancer: progression of ductal carcinoma in situ: the pathological perspective

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Expression of luminal and basal cytokeratins in human breast carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

The relationship between p63 and p53 expression in normal and neoplastic breast tissue

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Estrogen receptor-alpha and C-ERBB-4 expression in breast carcinomas

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Molecular portraits of human breast tumours

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3039794

Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution

7 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606021

Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606021

IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606021

Molecular alterations in columnar cell lesions of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606021

P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606021

The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606021

HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606021

Expression of maspin predicts poor prognosis in breast-cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606021

Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606021

Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6606021

Tissue microarrays for routine diagnostic assessment of HER2 status in breast carcinoma

21 January 2018

1 reference

12 December 2020

Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast

1 reference

12 December 2020

Topoisomerase IIalpha expression in ductal carcinoma in situ of the breast: a preliminary study

1 reference

12 December 2020

A Wilcoxon-type test for trend

1 reference

12 December 2020

Estrogen receptors in ductal carcinoma in situ of breast

1 reference

12 December 2020

Distribution of estrogen receptor in ductal carcinoma in situ of the breast

1 reference

12 December 2020

Beta 1 and beta 4 integrin expression in methacarn and formalin-fixed material from in situ ductal carcinoma of the breast

1 reference

12 December 2020

P-cadherin expression in breast carcinoma indicates poor survival

1 reference

12 December 2020

Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy

1 reference

12 December 2020

The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6606021

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

17 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

PubMed publication ID

21139586

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21139586%20AND%20SRC:MED&resulttype=core&format=json